Schiff Hardin hires new partner to generics practice

Law firm Schiff Hardin has hired a new partner to its global generic pharmaceuticals practice.

The new partner, Kevin Nelson, is joining the Chicago office, where he will be part of the firm’s pharmaceuticals and biologics patent team.

Nelson has more than 15 years of experience representing generic companies in patent litigation brought under the Hatch-Waxman Act.

Sailesh Patel, co-leader of the firm’s IP group, said: “In the past 12 months alone, we have been at eight pharma trials and evidentiary hearings, so Kevin’s arrival is well-timed.”

Besides Nelson’s extensive wor k in the pharmaceutical sector, he has also dealt with cases involving trademark and copyright infringement, false and unfair advertising, and unfair competition claims.

Did you enjoy reading this story?  Sign up to our free newsletter and get stories like this sent straight to your inbox.